11,735
Views
11
CrossRef citations to date
0
Altmetric
Research papers

Human rights, public health and medicinal cannabis use

&
Pages 51-61 | Received 07 Nov 2014, Accepted 01 Apr 2015, Published online: 28 Apr 2015

References

  • Alder, J. (2006). The sublime and the beautiful: Incommensurability and human rights. Public Law, 4, 697–721.
  • Aldrich, M. (1997). History of therapeutic cannabis. In M. L. Mathre (Ed.), Cannabis in medical practice: A legal, historical, and pharmacological overview of the therapeutic use of marijuana (pp. 35–55). Jefferson, NC: McFarland.
  • Beck, G. (2008). Human rights adjudication under the ECHR: Between value pluralism and essential contestability. European Human Rights Law Review, 2, 214–244.
  • Bedrocan Canada. (2014). About Bedrocan. Retrieved December 13, 2013, from https://bedrocan.ca/about-us/
  • Blainey, M. G. (2015). Forbidden therapies: Santo Daime, Ayahuasca, and the prohibition of entheogens in western society. Journal of Religion & Health, 54, 287–302.
  • Boister, N. (2001). Penal aspects of the UN drug conventions. The Hague: Kluwer.
  • Bone, M. (2014). Is the medicinal consumption of cannabis effectively regulated from a human rights perspective? In M. Bone, P. Mungroo, & Y. Ping (Eds.), London cannabis conference (pp. 28–35). London: The House of Lords.
  • Bone, M., Mungroo, P., & Ping, Y. (2014). Cannabis regulation: The World is moving forward, what is stopping us? London Cannabis Conference. London: The House of Lords.
  • Boorse, C. (1975). On the distinction between disease and illness. Philosophy and Public Affairs, 5, 49–68.
  • Buchanan, A. (2008). Human rights and the legitimacy of the international order. Legal Theory, 14, 39–70.
  • Bud Buddies. (n.d.). Bud Buddies: Project Storm. Retrieved July 17, 2014, from http://projectstormthefilm.com/
  • Bunton, R., & Coveney, J. (2011). Drugs’ pleasures. Critical Public Health, 21, 9–23.10.1080/09581596.2010.530644
  • Canadians for Safe Access. (n.d.). Cannabis research. Retrieved July 25, 2014, from http://safeaccess.ca/research/
  • Chapkis, W. (2007). Cannabis, consciousness, and healing. Contemporary Justice Review, 10, 443–460.10.1080/10282580701677550
  • Coggon, J. (2012). What makes health public? A critical evaluation of moral, legal, and political claims in public health. Cambridge: Cambridge University Press.
  • Conrad, P., & Barker, K. K. (2010). The social construction of illness: Key insights and policy implications. Journal of Health and Social Behavior, 51(Suppl. 1), S67–S79.10.1177/0022146510383495
  • Coomber, R., Oliver M., & Morris, C. (2003). Using cannabis therapeutically in the UK: A qualitative analysis. Journal of Drug Issues, 33, 325–356.10.1177/002204260303300204
  • Coveney, J., & Bunton, R. (2003). In pursuit of the study of pleasure: Implications for health research and practice. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 7, 161–179.
  • Curran, V. (2014). Cannabis: How can drug science inform drug policy? In M. Bone, P. Mungroo, & Y. Ping (Eds.), London cannabis conference (pp. 36–41). London: The House of Lords.
  • Di Forti, M., & Murray, R. M. (2014). An appropriate Legal and healthcare framework for cannabis use should take into account the effects of heavy use on mental health In M. Bone, P. Mungroo, & Y. Ping (Eds.), London cannabis conference (pp. 4–8). London: The House of Lords.
  • Donnelly, J. (2003). Universal human rights: In theory and practice (2nd ed.). New York, NY: Cornell University Press.
  • Edelstein, L. (1943). The hippocratic oath: Text, translation, and interpretation. Baltimore, MD: Johns Hopkins Press.
  • Foria. (2014). What is Foria? Retrieved August 25, 2014, from http://foriapleasure.com/pages/about-us
  • Global Drug Survey. (2014). The highway code: A Guide to safer more enjoyable drug use. Retrieved from http://www.globaldrugsurvey.com/brand/the-highway-code/
  • Guzman, M. (2003). Cannabinoids: Potential anti-cancer agents. Nature Reviews, 3, 745–755.
  • GW Pharmaceuticals. (2014). Sativex. Retrieved July 26, 2014, from http://www.gwpharm.com/Sativex.aspx
  • Hayry, M. (2004). Prescribing cannabis: Freedom, autonomy, and values. Journal of Medical Ethics, 30, 333–336.10.1136/jme.2002.001347
  • Hazekamp, A., & Heerdink, E. R. (2013). The prevalence and incidence of medicinal cannabis on prescription in The Netherlands. European Journal of Clinical Pharmacology, 69, 1575–1580.10.1007/s00228-013-1503-y
  • Holt, M., & Treloar, C. (2008). Pleasure and drugs. International Journal of Drug Policy, 19, 349–352.10.1016/j.drugpo.2007.12.007
  • Jones, C. (2006). Cannabis as an alternative medicine. Queens Health Sciences Journal, 8, 29–33.
  • Labonté, R. (2008). Global health in public policy: Finding the right frame? Critical Public Health, 18, 467–482.10.1080/09581590802443588
  • Leung, L. (2011). Cannabis and its derivatives: Review of medical use. The Journal of the American Board of Family Medicine, 24, 452–462.10.3122/jabfm.2011.04.100280
  • Lucas, P. (2008). Regulating compassion: An overview of Canada’s federal medical cannabis policy and practice. Harm Reduction Journal, 5(5), 1–13.
  • Mackenzie, R. (2011). The neuroethics of pleasure and addiction in public health strategies moving beyond harm reduction: Funding the creation of non-addictive drugs and taxonomies of pleasure. Neuroethics, 4, 103–117.10.1007/s12152-010-9074-4
  • Nickel, J. (2010). Human rights. The Stanford encyclopedia of philosophy. Retrieved July 28, 2014, from http://plato.stanford.edu/archives/spr2012/entries/rights-human/
  • Nutt, D. (2015). Illegal drugs laws: Clearing a 50-year-old obstacle to research. PLOS Biology, 13, e1002047.10.1371/journal.pbio.1002047
  • Nutt, N. J., King, L. A., & Nichols, D. E. (2013). Effects of schedule I DRUG laws on neuroscience research and treatment innovation. Nature Reviews/Neuroscience, 14, 577–585.
  • Perry, M. J. (1998). The Idea of human rights: Four inquiries. New York, NY: Oxford University Press.
  • Police Foundation, P. (2000). Drugs and the law: Report of the inquiry into the misuse of drugs act 1971. London: Police Foundation.
  • Powers, M., & Faden, R. (2006). Social justice: The moral foundations of public health and health policy. Oxford: Oxford University Press.
  • Race, K. (2009). Pleasure consuming medicine. Durham: Duke University Press.10.1215/9780822390886
  • Reiman, A. E. (2008). Self efficacy, social support and service integration at medicinal cannabis facilities in the San Francisco Bay area of California. Health and Social Care in the Community, 16, 31–41.
  • Rolles & Murkin. (2013). How to regulate cannabis: A practical guide. London: Transform Drug Policy Foundation.
  • Russo, E. B. (2005). Cannabis in India: Ancient lore and modern medicine. In R. Mechoulam (Ed.), Cannabinoids as therapeutics (pp. 1–22). Basel: Birkhauser Verlag.
  • Russo, E. B. (2007). History of cannabis and its preparations in saga, science, and sobriquet. Chemistry and Biodiversity, 4, 1614–1648.10.1002/cbdv.v4:8
  • Scott, G. (2013, November 15). Any positive change The evolving declaration of the Chicago recovery alliance. Hit hot topics conference, Liverpool: FACT Liverpool. Retrieved August 24, 2014, from http://hithottopics.com/index.php/conference/archives/2013-hot-topics
  • Sen, A. (2004). Health achievement and equity: External and internal perspectives In S. Anand, F. Peter, & A. Sen (Eds.), Public health, ethics and equity (pp. 263–268). Oxford: Oxford University Press.
  • Siegel, R. K. (2005). Intoxication: The universal drive for mind-altering substances. Vermont: Park Street Press.
  • Szasz, T. (2003). Ceremonial chemistry: The ritual persecution of drugs, addicts, and pushers (Revised ed.). Syracuse, NY: Syracuse University Press.
  • Tsakyrakis, S. (2009). Proportionality: An assault on human rights? International Journal of Constitutional Law, 7, 468–493.10.1093/icon/mop011
  • Tupper, K. (2008). The globalization of ayahuasca: Harm reduction or benefit maximisation? International Journal of Drug Policy, 19, 297–303.10.1016/j.drugpo.2006.11.001
  • Waldstein, A. (2010). Menace or medicine – Anthropological perspectives on the self-administration of high potency cannabis in the UK. Drugs and Alcohol Today, 10, 37–43.10.5042/daat.2010.0469
  • WHO. (1948/1998). Preamble of the Constitution of the World Health Organisation as adopted by the International Health Conference (Official Records of the WHO, No. 2) 100.
  • WHO. (n.d.). Trade, foreign policy, diplomacy and health: Glossary of globalization, trade and health terms. Retrieved December 10, 2014, from http://www.who.int/trade/glossary/story076/en/

Cases cited

  • City of Garden Grove v. Superior Court of Orange County, 68 Cal. Rptr. 3d 656 (Cal. Ct. App. (2007).
  • Conant v. Walters. ( 9th Cir 2002) 309 F.3d 629, cert denied Oct. 14, (2003).
  • Gonzales v. Raich ( previously Ashcroft v. Raich), 545 U.S. 1 (2005).
  • Hitzig v. Canada, CanLII 30796 (ON C.A.) (2003).
  • R v. Altham, EWCA Crim 7 (2006).
  • R v. Parker, 188 DLR (4th) 385 (2000).
  • R v. Quayle; R v. Wales; R v. Taylor and another; R v. Kenny; Attorney General’s Reference (No2 of 2004) EWCA Crim 1415 (2005).
  • United States v. Oakland Cannabis Buyers' Cooperative, 532 U.S. 483 (2001).